DRC Begins Bundibugyo Vaccine Trial as Deaths Exceed 4,600
ABUJA, Nigeria – The Democratic Republic of the Congo (DRC) has begun a clinical trial of vaccine candidates against the Bundibugyo virus following an…
Topic
CEPI
CEPI Invests $4.17m to Study Ebola Vaccine Protection Against Bundibugyo Virus
ABUJA, Nigeria – The Coalition for Epidemic Preparedness Innovations (CEPI) has committed $4.17 million to four research projects aimed at determining whether existing Ebola…
World’s First Bundibugyo Ebola Vaccine Trial Begins
ABUJA, Nigeria – The Coalition for Epidemic Preparedness Innovations (CEPI) has launched the world’s first human clinical trial of a Bundibugyo Ebola vaccine, marking…
WHO Roadmap Targets Pandemics, Boosts Global Research Readiness Worldwide
ABUJA, Nigeria – The World Health Organization unveils new global research and development roadmaps to strengthen preparedness for future pandemics, prioritising faster development of…
West Africa Unveils Regional Roadmap for Fair Lassa Fever Vaccine Access
ABIDJAN, Côte d’Ivoire – West African governments launch a landmark regional framework to guarantee equitable access to Lassa fever vaccines, once regulatory approvals are…
Oxford Launches First Human Trial of Lassa Vaccine
ABUJA, Nigeria – The global push to curb Lassa fever reaches a decisive turning point as scientists at the Oxford Vaccine Group administer the…